Models of pneumococcal disease

Carlos J. Orihuela; Elaine I. Tuomanen

doi:10.1016/j.ddmod.2006.03.001

Models of pneumococcal disease

Carlos J. Orihuela, Elaine I. Tuomanen

Microbiology, Immunology & Molecular Genetics

Research output: Contribution to journal › Review article

5 Scopus citations

Abstract

Streptococcus pneumoniae is a leading cause of invasive Gram-positive disease. Infection progresses from the nasopharynx to otitis, pneumonia, bacteremia, sepsis and meningitis. Steadily increasing multidrug resistance has forced testing of new antibiotics and vaccines, as well as new adjunctive therapies based on insights into pathogenesis. This review discusses the models for each disease manifestation from both the host and bacterial perspectives and their impact on discovery of new therapeutics.

Original language	English (US)
Pages (from-to)	69-75
Number of pages	7
Journal	Drug Discovery Today: Disease Models
Volume	3
Issue number	1
DOIs	https://doi.org/10.1016/j.ddmod.2006.03.001
State	Published - Apr 27 2006

ASJC Scopus subject areas

Molecular Medicine
Drug Discovery

Access to Document

10.1016/j.ddmod.2006.03.001

Fingerprint Dive into the research topics of 'Models of pneumococcal disease'. Together they form a unique fingerprint.

Cite this

Orihuela, C. J., & Tuomanen, E. I. (2006). Models of pneumococcal disease. Drug Discovery Today: Disease Models, 3(1), 69-75. https://doi.org/10.1016/j.ddmod.2006.03.001

@article{00f73d4ba2664898aad5595f84c8f77c,

title = "Models of pneumococcal disease",

abstract = "Streptococcus pneumoniae is a leading cause of invasive Gram-positive disease. Infection progresses from the nasopharynx to otitis, pneumonia, bacteremia, sepsis and meningitis. Steadily increasing multidrug resistance has forced testing of new antibiotics and vaccines, as well as new adjunctive therapies based on insights into pathogenesis. This review discusses the models for each disease manifestation from both the host and bacterial perspectives and their impact on discovery of new therapeutics.",

author = "Orihuela, {Carlos J.} and Tuomanen, {Elaine I.}",

year = "2006",

month = apr,

day = "27",

doi = "10.1016/j.ddmod.2006.03.001",

language = "English (US)",

volume = "3",

pages = "69--75",

journal = "Drug Discovery Today: Disease Models",

issn = "1740-6757",

publisher = "Elsevier Limited",

number = "1",

}

TY - JOUR

T1 - Models of pneumococcal disease

AU - Orihuela, Carlos J.

AU - Tuomanen, Elaine I.

PY - 2006/4/27

Y1 - 2006/4/27

N2 - Streptococcus pneumoniae is a leading cause of invasive Gram-positive disease. Infection progresses from the nasopharynx to otitis, pneumonia, bacteremia, sepsis and meningitis. Steadily increasing multidrug resistance has forced testing of new antibiotics and vaccines, as well as new adjunctive therapies based on insights into pathogenesis. This review discusses the models for each disease manifestation from both the host and bacterial perspectives and their impact on discovery of new therapeutics.

AB - Streptococcus pneumoniae is a leading cause of invasive Gram-positive disease. Infection progresses from the nasopharynx to otitis, pneumonia, bacteremia, sepsis and meningitis. Steadily increasing multidrug resistance has forced testing of new antibiotics and vaccines, as well as new adjunctive therapies based on insights into pathogenesis. This review discusses the models for each disease manifestation from both the host and bacterial perspectives and their impact on discovery of new therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=33645945620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645945620&partnerID=8YFLogxK

U2 - 10.1016/j.ddmod.2006.03.001

DO - 10.1016/j.ddmod.2006.03.001

M3 - Review article

AN - SCOPUS:33645945620

VL - 3

SP - 69

EP - 75

JO - Drug Discovery Today: Disease Models

JF - Drug Discovery Today: Disease Models

SN - 1740-6757

IS - 1

ER -